Roller-coaster healthcare stock Hims & Hers Health ( HIMS -1.34%), whose stock got devastated last week by worries that it ...

While Hims offers more ... But how do these two companies’ products and services compare? Read on for our full review and how to decide which one may work best for you. Our Medical Standards ...

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

Hims & Hers delivered Q4 2024 earnings that saw the stock sell off nearly 20% after hours. Find out why I rate HIMS stock a buy.

When investors get lucky enough to find one of them, it can typically bring on life-changing returns, even retiring them from active work if they ... sentiment seen in Hims & Hers stock recently ...

The testing will help Hims & Hers more readily offer a wider array of treatments, supplements, and medications for ailments that require blood work to be ... competitors to do this temporarily ...

Hims & Hers Health shares plunged in extended trading Monday after the online healthcare provider reported falling margins as costs rose.

Hims & Hers Health, Inc. (NYSE ... price of $499 per month for uninsured individuals or those whose insurance does not cover obesity treatments. Also Read: Hims & Hers Health Analyst Sees Buying ...

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Novo Nordisk’s Wegovy and Ozempic has been resolved.